Study To Assess FRacTure Healing With SclerosTin Antibody - Hip
Status:
Completed
Trial end date:
2013-05-10
Target enrollment:
Participant gender:
Summary
This is an international, multi-center study to determine the efficacy, safety, and
tolerability of romosozumab (AMG 785) in adults with a fresh unilateral hip fracture, status
post surgical fixation.